首页|骨化三醇软胶囊在中国健康志愿者体内的药动学及生物等效性

骨化三醇软胶囊在中国健康志愿者体内的药动学及生物等效性

扫码查看
建立了高灵敏度的LC-MS/MS法检测人血浆中骨化三醇的含量,定量下限达到20pg/mL,能够满足临床检测的需求.采用随机、开放、三周期、三交叉的试验设计,对骨化三醇的受试制剂与市售参比制剂在36名中国健康志愿者体内的药动学特征进行比较,考察二者的生物等效性.健康志愿者空腹单次口服给予骨化三醇软胶囊(4.0 μg),受试制剂与参比制剂的主要药动学参数tmax分别为(3.46±1.33)和(2.92±1.47)h;t1/2分别为(8.14±3.22)和(7.70±2.32)h;cmax分别为(160.68±52.41)和(169.00±50.26)pg/mL.并且,受试制剂与参比制剂的血浆药物浓度变化趋势一致,主要药动学参数几何均值比90%置信区间均在80.00%~125.00%,表明受试制剂与参比制剂具有生物等效性.
Pharmacokinetic and Bioequivalence Studies of Calcitriol Soft Capsules in Healthy Chinese Volunteers
A highly sensitive LC-MS/MS method was established for detecting calcitriol content in human plasma,with a lower limit of quantification of 20 pg/mL,which could meet the clinical detection needs.A randomized,open,three cycles,triple crossover design was used to investigate and compare the pharmacokinetic characteristics and bioequivalence between the tested preparation and the commercially available reference preparation of calcitriol in 36 healthy Chinese volunteers who were given a single oral administration of calcitriol soft capsules(at a dose of 4.0 pg)on an empty stomach.The results showed that the main pharmacokinetic parameters of the tested preparation and the reference preparation were as follows:tmax were(3.46±1.33)and(2.92±1.47)h,t1/2 were(8.14±3.22)and(7.70±2.32)h,cmax were(160.68±52.41)and(169.00±50.26)pg/mL,respectively.The variance in plasma concentrations of the tested and the reference preparations showed the same trend.The geometric mean ratios of the main pharmacokinetic parameters were within the 90%confidence interval of 80.00%-125.00%,indicating that the test and reference formulations were bioequivalent.

calcitriol soft capsulefastingpharmacokineticsbioequivalence

钱红、边静、陈阳生、杜昌余、张怀征、徐智儒

展开 >

中国医药工业研究总院,上海 201203

上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 200437

上海市生物物质成药性评价专业技术服务中心,上海 200437

正大制药(青岛)有限公司,山东青岛 266071

展开 >

骨化三醇软胶囊 空腹 药物动力学 生物等效性

2024

中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCD
影响因子:0.487
ISSN:1001-8255
年,卷(期):2024.55(9)
  • 2